Great Debates in Multiple Myeloma

The following abstracts represent the presentations given at IWWM-8 (London-2014) special session, Great Debates in Multiple Myeloma:

Session Chair: K. Anderson

Should patients with high risk smoldering myeloma receive treatment? [YES] O. Landgren (USA)

Should patients with high risk smoldering myeloma receive treatment? [NO] A. Palumbo (Italy)

Should triple therapy be the gold standard for frontline myeloma? [YES] N. Munshi (USA)

Should triple therapy be the gold standard for frontline myeloma? [NO] M. Dimopoulos (Greece)

Should autologous transplant be offered as consolidation to all eligible patients? [YES] B. Barlogie (USA)

Should autologous transplant be offered as consolidation to all eligible patients? [NO] JP Fermand (France)

Should pomalidomide or carfilzomib be the initial salvage treatment in myeloma? [POM] X. Leleu (France)

Should pomalidomide or carfilzomib be the initial salvage treatment in myeloma? [CAR] P. Moreau (France)

London 2014 Overview

Click here to display the London 2014 Overview page

London 2014 Organizers

CHAIR ORGANIZERS:

Shirley D'Sa MD
Charalampia Kyriakou MD, Ph.D
Roger Owen MD
Steven Treon MD Ph.D

ORGANIZING SECRETARIAT:

Christopher Patterson

SCIENTIFIC COMMITTEE:

Kenneth C Anderson MD
Bart Barlogie MD Ph.D
Meletios Dimopoulos MD
Jean-Paul Fermand MD
Morie Gertz MD
Irene Ghobrial MD
Marie-Jose Kersten MD Ph.D
Eva Kimby MD Ph.D
Sigurdur Kristinsson MD Ph.D
Robert Kyle MD
Ola Landgren MD PhD
Michael Lunn MD Ph.D
Veronique Leblond MD
Giampaolo Merlini MD
Pierre Morel MD
Enrica Morra MD
Nikhil Munshi MD
Jesus San Miguel MD PhD
Linda Pilarski Ph.D

London 2014 Faculty

Click here for a listing of the IWWM-8 London 2014 Faculty Speakers

London 2014 Program

Click here to download the IWWM-8 London 2014 conference program

London 2014 Sponsors

Click here for the IWWM-8 London 2014 sponsors

London 2014 Abstracts

Choose from the following list of IWWM-8 (London 2014) conference sessions:

Genetic Basis of WM I

Genetic Basis of WM II

Great Debates in Multiple Myeloma

Signaling in WM

Origin of the WM Cell

Diagnosis of WM

WM Predisposition

Great Debates in Waldenstrom's Macroglobulinemia

Novel Drug Development for WM

Prognostication and Survival in WM

Poster Discussion Session of Invited Abstracts

Current Therapy of WM

Treatment Considerations in WM

Special Topics in WM

London 2014 Task Force

IWWM-8 Task Force Publications

Recommendations for the diagnosis and initial evaluation of patients with Waldenström's Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström's Macroglobulinaemia

London 2014 Hotel & Travel

Click here for travel information for IWWM-8 London

Click here to go to the Park Plaza Westminster website

Click here for a "Walking Tour" of London's greatest scientific experiments

London 2014 Media Gallery

London 2014 Photos

Click on the desired photo gallery to display a selection of photos from that section of the conference.

Opening Ceremonies

London 2014 Faculty Presenters

London 2014 Conference

London 2014 Closing Ceremonies

London 2014 Doctor-Patient Forum

5th International Doctor-Patient Forum on WM, London 2014

Jointly sponsored by IWMF and WMUK. Patient Track Part of IWWM8 doctor workshop. Open to all, worldwide, including families of patients and interested medical professionals.

The 2014 International Forum is one of the most important events of 2014 for the WM community worldwide. It comes at the end of the IWWM8 (the 8th WM International Workshop) meeting for doctors organised by the Bing Centre for WM at Harvard, and a distinguished selection of the doctors coming to London from around the world will be with us on the Sunday to present the many new advances in treatment and care of WM. The highlight of the day is likely to be a presentation from Dr Steven Treon and his Dana-Farber team from the Bing Centre outlining the latest research and trials involving Ibrutinib (Imbruvica®), which is emerging as a breakthrough therapy in many B cell related diseases, including WM.

Please note this meeting was organized through the IWMF and WMUK. For more information, feel free to visit the IWMF website.